IMPY: An improved thioflavin-T derivative for in vivo labeling of β-amyloid plaques

Brain Research

Volumn 956, Issue 2, 2002, Pages 202-210

  Kung, Mei Ping ^a   Hou, Catherine ^a   Zhuang, Zhi Ping ^a   Zhang, Bin ^a   Skovronsky, Daniel ^a   Trojanowski, John Q ^a   Lee, Virginia M Y ^a   Kung, Hank F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Alzheimer's disease imaging agent; Amyloid plaque; Autoradiography; Radioiodinated probe; SPECT imaging

Indexed keywords

6 IODO 2 (4' DIMETHYLAMINO)PHENYLIMIDAZO[1,2 A]PYRIDINE I 123; 6 IODO 2 (4' DIMETHYLAMINO)PHENYLIMIDAZO[1,2 A]PYRIDINE I 125; AMYLOID BETA PROTEIN; FLUORESCENT DYE; HYDROGEN PEROXIDE; PYRIDINE DERIVATIVE; THIOFLAVINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DISTRIBUTION; DRUG SYNTHESIS; DRUG UPTAKE; HUMAN; HUMAN TISSUE; ISOTOPE LABELING; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENILE PLAQUE; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; AUTOPSY; AUTORADIOGRAPHY; FLUORESCENCE; HUMANS; MICE; MICE, TRANSGENIC; MOLECULAR PROBES; PYRIDINES; SENILE PLAQUES; THIAZOLES;

EID: 0037195577     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03436-4     Document Type: Article

References (36)

1. Agdeppa E.D., Kepe V., Liu J., Flores-Torres S., Satyamurthy N., Petric A., Cole G.M., Small G.W., Huang S.C., Barrio J.R. Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease. J. Neurosci. 21:2001;189.
2. 99mTc-MAMA-chrysamine G, a probe for beta-amyloid protein of Alzheimer's disease. Eur. J. Nucl. Med. 26:1999;1392-1399.
3. Dovey H.F., John V., Anderson J.P., Chen L.Z., de Saint Andrieu P., Fang L.Y. Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. J. Neurochem. 76:2001;173-181.
4. Ginsberg S.D., Schmidt M.L., Crino P.B., Eberwine J.H., Lee V.M.-Y., Trojanowski J.Q. Molecular pathology of Alzheimer's disease and related disorders. Peters A., Morrison J.H., Cerebral Cortex: Neurodegenerative and Age-related Changes in Structure and Function of Cerebral Cortex. 1999;603-654 Kluwer Academic/Plenum, New York.
5. Hou C., Kung M.P., Zhuang Z.-P., Skovronsky D.M., Gur T.L., Trojanowski J.Q., Lee V.M.-Y., Kung H.F. An improved radioiodinated Chrysamine G derivative for amyloid plaque detection in Alzheimer's disease. Proceedings of the Society for Neuroscience Program 31th Annual Meeting, San Diego, CA. 2001;. Abstract No. 323.11.
6. Hsiao K. Transgenic mice expressing Alzheimer amyloid precursor proteins. Exp. Gerontol. 33:1998;883-889.
7. Klunk W.E., Debnath M.L., Pettegrew J.W. Small-molecule beta-amyloid probes which distinguish homogenates of Alzheimer's and control brains. Biol. Psychiatry. 35:1994;627.
8. Klunk W.E., Debnath M.L., Pettegrew J.W. Chrysamine-G binding to Alzheimer's and control brain: autopsy study of a new amyloid probe. Neurobiol. Aging. 16:1995;541-548.
9. Klunk W.E., Wang Y., Huang G.-F., Debnath M.L., Holt D.P., Mathis C.A. Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. Life Sci. 69:2001;1471-1484.
10. Kung H., Lee C., Zhuang Z., Kung M., Hou C., Plossl K. Novel stilbenes as probes for amyloid plaques. J. Am. Chem. Soc. 123:2001;12740-12741.
11. M.-P. Kung, D. Skovronsky, C. Hou, Z.-P. Zhuang, T. Gur, B. Zhang, J. Trojanowski, V. Lee, H. Kung. Detection of amyloid plaques by radioligands for Aβ40 and Aβ42: Potential imaging agents in Alzheimer's patients, J. Mol. Neurosci. (2002) in press.
12. Kung M.P., Hou C., Zhuang Z.-P., Skovronsky D.M., Lee V.M.-Y., Trojanowski J.Q., Kung H.F. Radioiodinated ligands for mapping amyloid plaques in Alzheimer's disease. Proceedings of the Society for Neuroscience Program 30th Annual Meeting, New Orleans, LA. 2000;. Abstract No. 82.19.
13. 111In] chelation, conjugation to poly(ethylene glycol)-biotin linkers, and autoradiography with Alzheimer's disease brain sections. Bioconj. Chem. 11:2000;380-386.
14. Lee H.J., Zhang Y., Zhu C., Duff K., Pardridge W.M. Imaging brain amyloid of Alzheimer disease in vivo in transgenic mice with an Aβ peptide radiopharmaceutical. J. Cereb. Blood Flow Metab. 22:2002;223-231.
15. Lee V.M. Regulation of tau phosphorylation in Alzheimer's disease. Ann. NY Acad. Sci. 777:1996;107-113.
16. Mathis C.A., Bacskai B.J., Kajdasz S.T., McLellan M.E., Frosch M.P., Hyman B.T., Holt D.P., Wang Y., Huang G.-F., Debnath M.L., Klunk W.E. A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain. Bioorg. Med. Chem. Lett. 12:2002;295-298.
17. Mathis C.A., Holt D.P., Wang Y., Debnath M.L., Bacskai B.J., Hyman B.T., Klunk W.E. In vivo evaluation and imaging of a lipophilic derivative of Congo Red for amyloid assessment [abstract]. J. Nucl. Med. 42:2001;252.
18. Munson P.J., Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand binding system. Anal. Biochem. 107:1980;220-239.
19. 125I] labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer's disease amyloid of the A beta 1-40/vector complex. Proc. Natl. Acad. Sci. USA. 92:1995;10227-10231.
20. Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Liao Z., Lieberburg I., Motter R., Mutter L., Soriano F., Shopp G., Vasquez N., Vandevert C., Walker S., Wogulis M., Yednock T., Games D., Seubert P. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse [see comments]. Nature. 400:1999;173-177.
21. Schmidt M.L., Schuck T., Sheridan S., Kung M.-P., Kung H.F., Zhuang Z.-P., Bergeron C., Lamarche J.S., Skovronsky D., Giasson B.I., Lee V.M.-Y., Trojanowski J.Q. The fluorescent Congo Red derivative ( trans, trans )-1-bromo-2,5-bis-(3-hydroxycarbony-4-hydroxy)styrylbenzene (BSB) labels diverse β-pleated sheet structures in postmortem human neurodegenerative disease brains. Am. J. Pathol. 159:2001;937-943.
22. Selkoe D.J. The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. 8:1998;447-453.
23. Selkoe D.J. Biology of β-amyloid precursor protein and the mechanism of Alzheimer's disease. Terry R.D., Katzman R., Bick K.L., Sisodia S.S., Alzheimer's Disease. 1999;293-310 Lippincot/Williams & Wilkins, Philadelphia.
24. Selkoe D.J. Imaging Alzheimer's amyloid. Nature Biotechnol. 18:2000;823-824.
25. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81:2001;741-766.
26. Shoghi-Jadid K., Small G.W., Agdeppa E.D., Kepe V., Ercoli L.M., Siddarth P., Read S., Satyamurthy N., Petric A., Huang S.C., Barrio J.R., Liu J., Flores-Torres S., Cole G.M. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease: Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease. Am. J. Geriatr. Psychiatry. 10:2002;24-35.
27. Sinha S., Lieberburg I. Cellular mechanisms of beta-amyloid production and secretion. Proc. Natl. Acad. Sci. USA. 96:1999;11049-11053.
28. Skovronsky D., Zhang B., Kung M.-P., Kung H.F., Trojanowski J.Q., Lee V.M.-Y. In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 97:2000;7609-7614.
29. Styren S.D., Hamilton R.L., Styren G.C., Klunk W.E. X-34, a fluorescent derivative of Congo Red: a novel histochemical stain for Alzheimer's disease pathology. J. Histochem. Cytochem. 48:2000;1223-1232.
30. Thorsett E.D., Latimer L.H. Therapeutic approaches to Alzheimer's disease. Curr. Opin. Chem. Biol. 4:2000;377-382.
31. Vickers J.C., Dickson T.C., Adlard P.A., Saunders H.L., King C.E., McCormack G. The cause of neuronal degeneration in Alzheimer's disease. Prog. Neurobiol. 60:2000;139-165.
32. Wengenack T.M., Curran G.L., Poduslo J.F. Targeting Alzheimer's amyloid plaques in vivo. Nature Biotechnol. 18:2000;868-872.
33. Wu D., Yang J., Pardridge W.M. Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor. J. Clin. Invest. 100:1997;1804-1812.
34. Zhen W., Han H., Anguiano M., Lemere C.A., Cho C.G., Lansbury P.T. Jr. Synthesis and amyloid binding properties of rhenium complexes: preliminary progress toward a reagent for SPECT imaging of Alzheimer's disease brain. J. Med. Chem. 42:1999;2805-2815.
35. Zhuang Z.-P., Kung M.-P., Hou C., Plossel K., Skovronsky D., Gur T.L., Trojanowski J.Q., Lee V.M.-Y., Kung H.F. IBOX(2-(4′-dimethylaminophenyl)-6-iodobenzoxazole): a ligand for imaging amyloid plaques in the brain. Nucl. Med. Biol. 28:2001;887-894.
36. Zhuang Z.-P., Kung M.-P., Hou C., Skovronsky D., Gur T.L., Trojanowski J.Q., Lee V.M.-Y., Kung H.F. Radioiodinated styrylbenzenes and thioflavins as probes for amyloid aggregates. J. Med. Chem. 44:2001;1905-1914.